133 related articles for article (PubMed ID: 3174609)
1. The anti-CCK effect of glutaramic acid derivatives in anesthetized and conscious rats.
Takács T; Nagy I; Pap A; Varró V
Pancreas; 1988; 3(4):465-70. PubMed ID: 3174609
[TBL] [Abstract][Full Text] [Related]
2. The effect of CR 1409, a potent CCK receptor antagonist, on basal and stimulated pancreatic secretion in rat.
Takács T; Nagy I; Pap A; Varró V
Pancreas; 1990; 5(1):60-4. PubMed ID: 2293712
[TBL] [Abstract][Full Text] [Related]
3. [Inhibitory effect of CR 1409 (cholecystokinin antagonist) on pancreatic exocrine secretion in rats].
Shiratori K; Watanabe S; Shimizu K; Moriyoshi Y; Chang JH; Takeuchi T
Nihon Shokakibyo Gakkai Zasshi; 1989 Jan; 86(1):70-6. PubMed ID: 2471850
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of CR-1409, a competitive inhibitor of cholecystokinin, on pancreatic exocrine secretion in the conscious rat.
Miyasaka K; Nakamura R; Funakoshi A; Kitani K
Tohoku J Exp Med; 1988 Jun; 155(2):165-72. PubMed ID: 3212779
[TBL] [Abstract][Full Text] [Related]
5. Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat.
Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Digestion; 1989; 42(2):61-9. PubMed ID: 2475379
[TBL] [Abstract][Full Text] [Related]
6. Proglumide analogues CR 1409 and CR 1392 inhibit cholecystokinin-stimulated insulin release more potently than exocrine secretion from the isolated perfused rat pancreas.
Okabayashi Y; Otsuki M; Nakamura T; Fujii M; Tani S; Fujisawa T; Koide M; Hasegawa H; Baba S
Pancreas; 1990 May; 5(3):291-7. PubMed ID: 2188254
[TBL] [Abstract][Full Text] [Related]
7. [Inhibitory effect of a new proglumide derivative, loxiglumide, on CCK action in isolated rat pancreatic acini].
Fujii M; Otsuki M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Nihon Shokakibyo Gakkai Zasshi; 1989 Jan; 86(1):77-82. PubMed ID: 2471851
[TBL] [Abstract][Full Text] [Related]
8. Effect of CCK antagonists CR 1409 and CR 1505 on rat pancreatic exocrine secretion in vivo.
Shiratori K; Shimizu K; Watanabe S; Takeuchi T; Moriyoshi Y
Pancreas; 1989; 4(6):744-50. PubMed ID: 2813333
[TBL] [Abstract][Full Text] [Related]
9. Effect of proglumide on rat pancreatic growth.
Yamaguchi T; Tabata K; Johnson LR
Am J Physiol; 1985 Aug; 249(2 Pt 1):G294-8. PubMed ID: 2411150
[TBL] [Abstract][Full Text] [Related]
10. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557
[TBL] [Abstract][Full Text] [Related]
11. Biological effects of a proglumide derivative as cholecystokinin antagonist in conscious dogs.
Hildebrand P; Beglinger C; Köhler E; Setnikar I; Gyr K
Regul Pept; 1987 Aug; 18(3-4):213-20. PubMed ID: 3446223
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of the cholecystokinin antagonist loxiglumide on pancreatic exocrine secretion and pancreatic growth in conscious rats.
Taguchi S; Green GM; Nakano I; Hatta Y
Int J Pancreatol; 1992 Apr; 11(2):67-73. PubMed ID: 1607730
[TBL] [Abstract][Full Text] [Related]
13. CR-1409: a potent inhibitor of cholecystokinin-stimulated amylase release and cholecystokinin binding in rat pancreatic acini.
Iwamoto Y; Yamamoto R; Kuzuya T
Pancreas; 1987; 2(1):85-90. PubMed ID: 2437574
[TBL] [Abstract][Full Text] [Related]
14. Effect of proglumide, a cholecystokinin receptor antagonist, on caerulein-stimulated pancreatic enzyme secretion and pancreatic polypeptide release in the dog.
Fried M; Beglinger C; Koehler E; Whitehouse I; Varga L; Gyr K
Regul Pept; 1984 Mar; 8(2):117-22. PubMed ID: 6729149
[TBL] [Abstract][Full Text] [Related]
15. New proglumide-analogue CCK receptor antagonists: very potent and selective for peripheral tissues.
Niederau C; Niederau M; Williams JA; Grendell JH
Am J Physiol; 1986 Jun; 250(6 Pt 1):G856-60. PubMed ID: 2424321
[TBL] [Abstract][Full Text] [Related]
16. Proglumide stimulates basal pancreatic secretion in the conscious rat.
Miyasaka K; Kurosawa H; Kitani K
Digestion; 1987; 37(3):135-43. PubMed ID: 3653528
[TBL] [Abstract][Full Text] [Related]
17. Different peripheral and central antagonistic activity of new glutaramic acid derivatives on satiety induced by cholecystokinin in rats.
Makovec F; Bani M; Chistè R; Revel L; Rovati LC; Setnikar I
Regul Pept; 1986 Dec; 16(3-4):281-90. PubMed ID: 3562900
[TBL] [Abstract][Full Text] [Related]
18. Effect of a new potent CCK antagonist, lorglumide, on caerulein- and bombesin-induced pancreatic secretion and growth in the rat.
Scarpignato C; Varga G; Dobronyi I; Papp M
Br J Pharmacol; 1989 Mar; 96(3):661-9. PubMed ID: 2470456
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of pentagastrin- and cholecystokinin-stimulated exocrine secretion by proglumide.
Loewe CJ; Grider JR; Gardiner J; Vlahcevic ZR
Gastroenterology; 1985 Oct; 89(4):746-51. PubMed ID: 2863192
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic secretory and trophic response to caerulein in rats: effect of proglumide and lorglumide.
Varga G; Papp M; Scarpignato C
Fundam Clin Pharmacol; 1989; 3(3):295-306. PubMed ID: 2475419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
